Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00977275 · ClinicalTrials.gov registry record · Phase 1
Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT00977275: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00977275 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00977275, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate radiation therapy directed to a small region of the breast in women who were recently diagnosed with early stage invasive breast cancer.
Interventions
- RADIATION Interstitial Implant Brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 1997-06 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00977275
The ClinicalTrials.gov registry entry for NCT00977275 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Interstitial Implant Brachytherapy is the first listed.
NCT00977275 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00977275 about?
NCT00977275 is a clinical study titled "Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant". The purpose of this study is to evaluate radiation therapy directed to a small region of the breast in women who were recently diagnosed with early stage invasive breast cancer.
What is the current status of trial NCT00977275?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 1997-06. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00977275?
The interventions under investigation include: Interstitial Implant Brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT00977275?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.